2m 2m 2m 2m 2m 2m 2m
SOLIGENIX (SNGX)
NASDAQ
$0.37+$0.001 (+0.33%)
Price as of Oct 02, 2026 4:45 PM EDT- $7.9MMarket Cap
- -71.58%1-Year Change
- BiotechnologyIndustry
SOLIGENIX (SNGX)
$0.37+$0.001 (+0.33%)
SNGX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.36 | ||
Change | +$0.002 (+0.50%) | ||
Open | $0.36 | ||
High | $0.37 | ||
Low | $0.36 | ||
Previous Close | $0.36 | ||
Volume | 52,000 | ||
30-Day Average Volume | 220,339 | ||
1-Week Change | -5.80% | ||
1-Month Change | -3.24% | ||
1-Year Change | -71.58% | ||
3-Year Change | -95.92% | ||
5-Year Change | -99.86% | ||
Fundamentals | |||
Shares Outstanding | 21.8M | ||
Total Assets | $10.5M | ||
Market Cap | $7.9M | ||
Enterprise Value | -$1.9M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$2.0M | ||
Free Cash Flow | -$1.7M | ||
EBIT | -$2.0M | ||
EBITDA | -$2.0M | ||
Net Working Capital | $6.5M | ||
EPS | -$0.12 | ||
Enterprise Value/EBITDA | 1 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -3 | ||
PEG | -0 | ||
Price/Free Cash Flow | -5 | ||
Price/Operating Cash Flow | -5 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 16 | ||
Last Split Date | 06/06/2024 | ||
Earnings & Revenue